Wells Fargo & Company Medical Devices

Wells Fargo & Company

$434 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
MXCT Maxcyte, Inc.	$361M	$186,000 0.0% of portfolio	48,035	Q3 2024 Added 4.49%
NNOX Nano X Imaging Ltd.	$332M	$180,000 0.0% of portfolio	29,760	Q3 2024 Reduced 2.36%
CUTR Cutera Inc	$6.26M	$169,000 0.0% of portfolio	215,185	Q3 2024 Reduced 19.73%
CERS Cerus Corp	$317M	$163,000 0.0% of portfolio	94,022	Q3 2024 Reduced 7.22%
IRMD Iradimed Corp	$669M	$155,000 0.0% of portfolio	3,092	Q3 2024 Reduced 2.0%
ANIK Anika Therapeutics, Inc.	$248M	$139,000 0.0% of portfolio	5,662	Q3 2024 Reduced 7.29%
RCEL Avita Medical, Inc.	$334M	$105,000 0.0% of portfolio	9,871	Q3 2024 Reduced 3.05%
INGN Inogen Inc	$214M	$105,000 0.0% of portfolio	10,886	Q3 2024 Added 4.17%
LUNG Pulmonx Corp	$253M	$102,000 0.0% of portfolio	12,385	Q3 2024 Reduced 0.15%
FNA Paragon 28, Inc.	$771M	$98,000 0.0% of portfolio	14,814	Q3 2024 Reduced 1.81%
TMCI Treace Medical Concepts, Inc.	$434M	$98,000 0.0% of portfolio	17,027	Q3 2024 Reduced 11.39%
NVRO Nevro Corp	$160M	$92,000 0.0% of portfolio	16,624	Q3 2024 Added 0.56%
VMD Viemed Healthcare, Inc.	$334M	$77,000 0.0% of portfolio	10,563	Q3 2024 Reduced 3.8%
SGHT Sight Sciences, Inc.	$192M	$68,000 0.0% of portfolio	10,819	Q3 2024 Reduced 3.81%
QIPT Quipt Home Medical Corp.	$85.3M	$53,000 0.0% of portfolio	18,226	Q3 2024 Added 3.95%
CVRX Cv Rx, Inc.	$306M	$42,000 0.0% of portfolio	4,779	Q3 2024 Reduced 3.28%
TELA Tela Bio, Inc.	$57.7M	$42,000 0.0% of portfolio	16,718	Q3 2024 New
ICAD Icad Inc	$40M	$41,000 0.0% of portfolio	26,140	Q3 2024 Reduced 56.25%
MASS 908 Devices Inc.	$80.9M	$40,000 0.0% of portfolio	11,738	Q3 2024 Reduced 0.58%
PROF Profound Medical Corp.	$157M	$38,000 0.0% of portfolio	4,784	Q1 2024 Added 41.92%
NPCE Neuro Pace Inc	$241M	$29,000 0.0% of portfolio	4,204	Q3 2024 Reduced 34.0%
BWAY Brainsway Ltd.	$160M	$25,000 0.0% of portfolio	2,717	Q3 2024 Added 3,781.43%
BFLY Butterfly Network, Inc.	$561M	$22,000 0.0% of portfolio	12,887	Q3 2024 Reduced 11.53%
DCTH Delcath Systems, Inc.	$83.9M	$22,000 0.0% of portfolio	2,453	Q3 2024 Reduced 16.93%
AZYO Aziyo Biologics, Inc.	$13.5M	$17,000 0.0% of portfolio	12,235	Q3 2024 New
SENS Senseonics Holdings, Inc.	$149M	$10,000 0.0% of portfolio	30,977	Q3 2024 Reduced 67.84%
EDAP Edap Tms Sa	$89.3M	$8,000 0.0% of portfolio	3,500	Q1 2020 New
ELMD Electromed, Inc.	$244M	$6,000 0.0% of portfolio	300	Q3 2024 New
NVNO En V Veno Medical Corp	$32.3M	$6,000 0.0% of portfolio	2,000	Q2 2024 Reduced 4.53%
LUCD Lucid Diagnostics Inc.	$38.6M	$2,000 0.0% of portfolio	2,463	Q3 2024 Reduced 28.88%
CODX Co Diagnostics, Inc.	$34.1M	$1,000 0.0% of portfolio	1,175	Q3 2024 Added 327.27%
BIO-B Bio Rad Laboratories, Inc.	$11.2B	$0 0.0% of portfolio	-	Q2 2023 Added 203.57%
CLPT Clear Point Neuro, Inc.	$290M	$0 0.0% of portfolio	69	Q3 2024 Added 176.0%
CTSO Cytosorbents Corp	$41.4M	$0 0.0% of portfolio	250	Q3 2024 Reduced 44.81%
FONR Fonar Corp	$108M	$0 0.0% of portfolio	14	Q2 2024 Reduced 75.0%
LNSR Lensar, Inc.	$79.9M	$0 0.0% of portfolio	189	Q2 2024 Reduced 27.59%
NMTC Neuroone Medical Technologies Corp	$11M	$0 0.0% of portfolio	333	Q3 2024 New
OM Outset Medical, Inc.	$40.3M	$0 0.0% of portfolio	11	Q2 2024 Reduced 99.93%
XTNT Xtant Medical Holdings, Inc.	$43.3M	$0 0.0% of portfolio	1	Q2 2024 Reduced 99.73%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.